483
Aurobindo Pharma LimitedAurobindo Pharma Limited – FDA 483, Feb 10, 2026
Record Details
An FDA Form 483 was issued to Aurobindo Pharma Limited, Unit VII, detailing multiple deficiencies in their manufacturing and quality control processes. Observations included issues with equipment cleaning, computer system controls, master production records, complaint handling, and investigation of discrepancies. The report indicates a need for significant improvements in quality systems and adherence to CGMP requirements.
View Company Profile
ID · fa93be5a-0031-4676-b411-4813d0c7f1aa
Other documents for Aurobindo Pharma Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.